<< Back to News

System Formulary Update
Calaspargase pegol-mknl (Asparlas)

Situation

Calaspargase pegol-mknl (Asparlas) 3,750 mg/5 mL SDV for injection was approved for addition to the health system formulary at the November 2022 System Pharmacy and Therapeutics Committee meeting

Background

The following medication was reviewed: Calaspargase pegol-mknl (Asparlas) 3,750 mg/5 mL SDV for injection

Assessment/Recommendations

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Calaspargase pegol-mknl (Asparlas) 3,750 mg/5 mL SDV for injection

Note: Stock of this formulary product may vary at individual entities

Formulary/Epic changes will Go-Live on Tuesday, November 29, 2022.